Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chandrashekar
Chandrashekar Aswathanarayanappa, Bangalore Karnataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20110118480 | METHOD OF SYNTHESIZING A SUBSTANTIALLY MONODISPERSED MIXTURE OF OLIGOMERS - The present invention relates to methods of synthesizing oligomeric compounds, and more particularly, to methods of synthesizing oligomer compounds comprising polyethylene glycol moieties. The present invention provides improved methods for synthesizing oligomers comprising polyethylene glycol moieties. Methods according to embodiments of the present invention may utilize reaction conditions that are milder, efficacious than those taught by conventional methods. | 05-19-2011 |
Chandrashekar Aswathanarayanappa, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100168201 | Polymorphs of [R-(R*, R*) ]-2-(4-Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-P- yrrole-1-Heptanoic Acid Magnesium Salt (2:1) - Crystalline and amorphous polymorphic forms of Atorvastatin magnesium and processes for their preparation are claimed. | 07-01-2010 |
Chandrashekar Aswathanarayanappa, Karnataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20120022274 | Crystalline Form of Orlistat and a Process Thereof - The present disclosure provides a crystalline form of orlistat, particularly form A of orlistat. The characterization of said form is performed using X-ray diffraction studies, IR and Differential Scanning calorimetry melting endotherm studies. Also, the disclosure provides a simple process to arrive at said crystalline form. | 01-26-2012 |
Chandrashekar Giliyar, Salt Lake City, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20100136105 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS - The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present invention include a carrier, where the carrier is formed from a combination of a triglyceride and at least two surfactants, at least one of which is hydrophilic. Upon dilution with an aqueous medium, the carrier forms a clear, aqueous dispersion of the triglyceride and surfactants. | 06-03-2010 |
| 20100137271 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS - Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs are provided. The pharmaceutical compositions include a therapeutically effective amount of a hydrophobic drug, preferably a steroid; a solubilizer, and a surfactant. The synergistic effect between the hydrophobic drug and the solubilizer results in a pharmaceutical formulation with improved dispersion of both the active agent and the solubilizer. As a result of the improved dispersion, the pharmaceutical composition has improved bioavailability upon administration. Methods of improving the bioavailability of hydrophobic drugs administered to a patient are also provided. | 06-03-2010 |
| 20100173882 | Steroidal Compositions - Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals. Also provided herein are compositions comprising testosterone and/or testosterone derivatives suitable for providing therapeutically effective and safe amounts of testosterone over periods of time. Further provided are methods of treating andro- and/or testosterone deficiency in individuals by administering to the individuals compositions described herein. | 07-08-2010 |
| 20110312927 | Progesterone Containing Oral Dosage Forms and Related Methods - The present invention provides for progesterone containing pharmaceutical oral dosage forms and related methods. The oral dosage forms can each include an amount of progesterone as well as a pharmaceutically acceptable carrier. The oral dosage forms can be formulated to have at least one of the following characteristics: the oral dosage form produces an pregnane metabolite mean blood plasma level of less than about 1000 nmol/L; the oral dosage form produces an pregnane metabolites mean blood plasma level, after administration of single dose of progesterone composition, such that the ratio of pregnane metabolite level to parent progesterone level of less than 10:1; has a dissolution rate in vitro, when measure using a USP Type-1 dissolution apparatus in 900 mL of deionized water with 2.0% (w/v) of sodium lauryl sulfate at 100 rpm, such that the oral dosage form releases at least 10 wt % of the progesterone within the first 30 minutes and/or releases less than 45 wt % in the first 4 hours; and the oral dosage form produces a ratio of mean plasma progesterone AUC to the amount of progesterone administered of more than 1.5×10 | 12-22-2011 |
| 20110312928 | Progesterone Containing Oral Dosage Forms and Related Methods - The present invention provides for progesterone containing pharmaceutical oral dosage forms and related methods. The oral dosage forms can each include an amount of progesterone as well as a pharmaceutically acceptable carrier. The oral dosage forms can be formulated to have at least one of the following characteristics: the oral dosage form produces an pregnane metabolite mean blood plasma level of less than about 1000 nmol/L; the oral dosage form produces an pregnane metabolites mean blood plasma level, after administration of single dose of progesterone composition, such that the ratio of pregnane metabolite level to parent progesterone level of less than 10:1; has a dissolution rate in vitro, when measure using a USP Type-1 dissolution apparatus in 900 mL of deionized water with 2.0% (w/v) of sodium lauryl sulfate at 100 rpm, such that the oral dosage form releases at least 10 wt % of the progesterone within the first 30 minutes and/or releases less than 45 wt % in the first 4 hours; and the oral dosage form produces a ratio of mean plasma progesterone AUC to the amount of progesterone administered of more than 1.5×10−6 hr/mL:1. | 12-22-2011 |
Chandrashekar Nelogal, Round Rock, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120079136 | System and Method for Dynamically Configuring a Target Device - In accordance with the present disclosure, a method for dynamically configuring a target device comprises receiving by one or more ports of a target device one or more initiator identifiers from one or more initiators. The method further comprises determining whether a plurality of ports received initiator identifiers from a common initiator. The method further comprises configuring the plurality of the ports to operate as a single, logical port if the plurality of ports received initiator identifiers from a common initiator. | 03-29-2012 |
| 20120079317 | SYSTEM AND METHOD FOR INFORMATION HANDLING SYSTEM REDUNDANT STORAGE REBUILD - Out-of-order reconstruction of a RAID storage device at a replacement storage device enables the replacement storage device to execute I/O for reconstructed regions during reconstruction of the replacement storage device. In one embodiment, the failed storage device is analyzed to find recoverable information, which is copied to the replacement storage device to reduce the need for reconstruction. In another embodiment, the priority for region's reconstruction is increased upon detection of an I/O to the region. The I/O is queued until reconstruction of the region and then executed after reconstruction of that region so that I/O at the region need not be repeated during reconstruction of the remainder of the replacement storage device. | 03-29-2012 |
Chandrashekar Padubidri, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090312969 | SYSTEM TO MAKE CONSUMERS AWARE OF ELECTRICITY USAGE - Energy usage of a plurality of appliances is measured using a single meter. A pattern of energy usage with respect to the plurality of appliances is determined dependent upon the measured energy usage, appliance details of the plurality of appliances, and usage hours of the plurality of appliances. The pattern is provided to a user of the appliances. | 12-17-2009 |
Chandrashekar Pathakoti, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100023518 | ORDERING TELEMETRY MESSAGES - A method for ordering telemetry messages containing attributes individually not sufficient to establish total ordering is provided. An initial rank value is assigned for a first telemetry message. For a subsequent telemetry message, it is determined if an attribute of the subsequent telemetry message indicates an ordering of the subsequent telemetry message with respect to the first telemetry message. If the attribute indicates the ordering of the subsequent telemetry message, a subsequent rank value is assigned to the subsequent telemetry message one higher than a highest rank value already assigned, otherwise a correct slot of the subsequent message is determined by minimizing a distance from an S slot corresponding to the highest rank value already assigned to a first non-empty slot by application of a Lazy Walker algorithm. | 01-28-2010 |
Chandrashekar Siddappa, Orlando, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100235022 | CONTROL OF THROTTLE AND BRAKING ACTIONS AT INDIVIDUAL DISTRIBUTED POWER LOCOMOTIVES IN A RAILROAD TRAIN - A method for controlling first ( | 09-16-2010 |
Chandrashekar Srinivasa-Murthy, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080240407 | Method, Computer Program Product, and Apparatus for Transferring a Call and Associated Data and an Associated System Thereof - A method, computer program product, and an apparatus for transferring a telephone call and associated data from an IVR system to a live agent or other system are provided. An exemplary embodiment may include a voice portal of the IVR system requesting an access number for a live agent and sending data associated with the telephone call to a CTI system. The CTI system may request and receive a routing label from a router and then send the data associated with the telephone call and the request for an access number to a call center using the routing label provided by the router. The CTI system may receive the access number from the call center and send the access number back through the IVR system to an exchange carrier for transferring the caller to the call center. | 10-02-2008 |
Chandrashekar Tippur, San Marcos, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120005322 | Stateless-agentless system and method of managing data in a computing environment - A data management system and method including a point of control configured to manage one or more target systems. The point of control divides a command sequence into a number of individual commands, and provides the individual commands to the stateless-agentless target system for execution. Furthermore, the point of control maintains the state of the command sequence and monitors the target system. As such, the target system is both “stateless” (i.e., the target system maintains no state information related to the command sequence) and “agentless” (i.e., the target system includes no software for the purpose of monitoring the target system. | 01-05-2012 |